Johnson Pharmacare Share Price Targets 2025, 2026 to 2030

Johnson Pharmacare Share Price Target 2025: Johnson Pharmacare, a major player in the pharmaceutical and healthcare industry, has built a reputation for providing high-quality medical solutions and innovative products.

With the global healthcare sector undergoing rapid changes due to growth in biotechnology, demand for affordable medicines, and an increased focus on preventive care – Johnson Pharmacare is well-positioned to take advantage of these trends. However, factors such as regulatory challenges, competition, and economic conditions could impact its growth.

In this detailed analysis, we will discuss in depth the key drivers, fundamentals, Shareholding patter, competitors, and expert estimates to provide a comprehensive view of Johnson Pharmacare’s stock price target for 2025 from January to December.

Whether you are an investor or simply interested in the pharmaceutical sector, this analysis provides valuable insights to guide your financial decisions.

Johnson Pharmacare Fundamental Analysis

• Market Cap: ₹53.90 Cr.
• ROE: -0.35%
• ROCE: -0.33%
• P/E Ratio: 0
• P/B Ratio: 0.95
• Div. Yield: 0%
• Book Value: ₹1.03
• Face Value: ₹1
• EPS (TTM): ₹0
• 52 Week High: ₹1.44
• 52 Week Low: ₹0.68

Also Read: Johnson Pharmacare Share Price Target

Johnson Pharmacare Share Price Chart

Johnson Pharmacare Share Price Target 2025 (Prediction)

Also Read: Info Edge Share Price Target

Johnson Pharmacare Shareholding Pattern

• Retail & Other: 100%
• Promoters: NA
• Foreign Institutions: NA
• Mutual Funds: NA
• Other Domestic Institutions: NA

Factors Affecting the Johnson Pharmacare Share Price

1. Launch of new pharmaceutical products: Johnson Pharmacare’s ability to introduce innovative and high-demand pharmaceutical products, such as generics, biosimilars, or specialty drugs, will be a key driver of growth. Successful launches can significantly boost revenue and investor confidence.
2. Expansion into emerging markets: Johnson Pharmacare’s strategy to expand into emerging markets, where demand for healthcare is growing rapidly, could open up new revenue sources. Success in these regions will attract investor interest and positively impact the stock price.
3. R&D investments in key therapeutic areas: Increased investments in research and development (R&D) for critical therapeutic areas such as oncology, cardiovascular diseases, and immunology can lead to breakthrough treatments. Strong R&D performance will enhance the company’s long-term growth potential.
4. Pricing pressure and competition: The pharmaceutical industry faces intense competition and pricing pressure, especially in generic drugs. Johnson Pharmacare’s ability to maintain competitive pricing while ensuring profitability will be key to sustaining stock price growth.
5. Regulatory approvals and compliance: The pharmaceutical industry is highly regulated, and Johnson Pharmacare’s stock price will depend on its ability to obtain timely approvals for new drugs and maintain compliance with global regulatory standards. Delays or issues could negatively impact growth prospects.

Also Read: Burnpur Cement Share Price Target

Johnson Pharmacare Key Competitors/Peer Companies

1. Nykaa
2. Vishal Mega Mart
3. Brainbees Solutions
4. Aegis Logistics
5. Redtape
6. Cello World
7. MMTC
8. Medplus Health Services
9. PDS International
10. Honasa Consumer

Also Read: KRN Heat Exchanger Share Price Target

To connect with us, click on any of the given social media buttons.

Disclaimer: The information in this article is for educational purposes only, and the targets mentioned in it are given as suggestions by market analysts. Therefore, before investing your money in any company, it is mandatory to get complete information about the company and consult your financial advisor.

Disclaimer: The stock market updates shared by DateUpdateGo are solely for general information and learning purpose only. They are not meant to serve as an investment advice. Individuals should always seek guidance from a certified financial advisor before making any investment-related choices.